Physician profile
Benjamin R Ford
NPI 1871932749
$10,946.07
in general payments reported to CMS, 2019-2025
24 companies · $182 in 2025
The $182 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,433 · 2020: $1,027 · 2021: $230 · 2022: $2,886 · 2023: $2,595 · 2024: $1,592 · 2025: $182.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,535 · Grant: $1,428 · Travel and Lodging: $1,407.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,534.51 |
| Grant | $1,427.70 |
| Travel and Lodging | $1,407.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $7,970.12 | 2019-2024 | Da Vinci Surgical System |
| Cook Incorporated | $1,427.70 | 2023 | |
| Cook Medical LLC | $536.85 | 2023 | Zilver Ptx |
| W. L. Gore & Associates, INC. | $229.79 | 2023 | Seamguard |
| Stryker Corporation | $181.31 | 2021-2024 | 1788 |
| Davol INC. | $97.66 | 2023-2025 | Phasix Mesh, Bard 3dmax Mesh |
| Vantive US Healthcare LLC | $86.23 | 2025 | Renal - Pd |
| Smith+Nephew, INC. | $53.38 | 2023 | Stravix, Grafix Pl |
| Abbott Laboratories | $50.00 | 2019-2022 | |
| Novo Nordisk INC | $45.93 | 2019-2024 | Rybelsus, Ozempic |
| Lupin INC. | $32.21 | 2019 | |
| Medtronic, INC. | $25.97 | 2024 | Endurant Iis |
| Hologic Sales and Service, LLC | $23.63 | 2023 | Coolseal Generator |
| Kerecis Limited | $21.61 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Baxter Healthcare | $21.04 | 2023 | Seprafilm |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Innovation Technologies INC | $19.89 | 2025 | Irrisept |
| Daiichi Sankyo INC. | $17.09 | 2023 | Injectafer |
| Medtronic USA, INC. | $16.08 | 2020 | |
| Endo Pharmaceuticals INC. | $15.71 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $15.56 | 2021 | |
| Exeltis, USA INC. | $15.40 | 2022 | |
| Bioventus LLC | $15.12 | 2023 | |
| Lemaitre Vascular, INC. | $14.99 | 2024 | Artegraft Vascular Graft |
| Tela Bio, INC. | $12.80 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benjamin Ford listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.